Press Releases

All Releases
View Summary Institutional Shareholder Services Inc. And Glass Lewis Recommend That Shareholders Of Mallinckrodt And Questcor Vote FOR Mallinckrodt's Acquisition Of Questcor
Aug 4, 2014
PDF 21.0 KB Add to Briefcase
View Summary Questcor Reports Record Second Quarter Financial Results
Jul 24, 2014
PDF 51.7 KB Add to Briefcase
View Summary Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction
Jul 14, 2014
PDF 17.5 KB Add to Briefcase
View Summary Questcor Pharmaceuticals Closes Transaction to Acquire International Rights to Synacthen® and Synacthen® Depot
Jun 23, 2014
PDF 12.3 KB Add to Briefcase
View Summary Questcor Provides Support to Lupus Foundation of America Awareness, Education and Advocacy Efforts
Jun 3, 2014
PDF 9.4 KB Add to Briefcase
View Summary Questcor Receives "Recognition of Appreciation" Award from MS Views & News
May 28, 2014
PDF 9.9 KB Add to Briefcase
View Summary Questcor Enters Into Development Collaboration Agreement Covering Novel Receptor-Selective Melanocortin Peptides
May 14, 2014
PDF 11.6 KB Add to Briefcase
View Summary Mallinckrodt Pharmaceuticals and Questcor Pharmaceuticals Announce Early Termination of HSR Act Waiting Period
May 12, 2014
PDF 20.3 KB Add to Briefcase
View Summary Clinical Trial Results Indicate Acthar May Significantly Reduce Disease Activity in Patients with Systemic Lupus Erythematosus
May 5, 2014
PDF 15.0 KB Add to Briefcase
View Summary Questcor Reports First Quarter Financial Results
Apr 28, 2014
PDF 40.9 KB Add to Briefcase
View Summary Questcor to Report First Quarter Financial Results on April 28, 2014
Apr 24, 2014
PDF 7.4 KB Add to Briefcase
View Summary Clinical Trial Results Indicate Acthar May Significantly Reduce Proteinuria in Patients with Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy
Apr 21, 2014
PDF 14.3 KB Add to Briefcase
View Summary Questcor Partners with National Kidney Foundation as National Sponsor of Kidney Walk
Apr 17, 2014
PDF 9.1 KB Add to Briefcase
View Summary Questcor Announces Quarterly Cash Dividend
Apr 7, 2014
PDF 7.3 KB Add to Briefcase
View Summary Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Enter Into Definitive Merger Agreement Under Which Mallinckrodt Will Acquire Questcor For Approximately $5.6 Billion, Creating A Diversified, High-Growth Specialty Pharmaceuticals Company
Apr 7, 2014
PDF 32.3 KB Add to Briefcase
View Summary Questcor Contributes $175,000 to Endowment of Philip R. Dodge Young Investigator Award for Pediatric Neurology
Mar 20, 2014
PDF 11.7 KB Add to Briefcase
View Summary Questcor Reports Fourth Quarter and Full Year 2013 Financial Results
Feb 25, 2014
PDF 45.8 KB Add to Briefcase
View Summary Questcor Announces Quarterly Cash Dividend
Feb 14, 2014
PDF 7.3 KB Add to Briefcase
View Summary Questcor to Report Fourth Quarter and Full Year 2013 Financial Results on February 25, 2014
Feb 12, 2014
PDF 8.4 KB Add to Briefcase
View Summary Questcor Pharmaceuticals Expands Senior Management Team
Feb 5, 2014
PDF 10.6 KB Add to Briefcase
Showing 1-20 of 260 Page: 1 2 3 ... 13  Next 20
=add release to Briefcase